BioSpace News Archive

CEO Dr. Myla Lai-Goldman named Executive Chairperson

This new partnership will provide unparalleled value to its current and future customer base which includes thousands of regulatory affairs professionals.

Funding Will Support Global Clinical Program

Boehringer Ingelheim collaborates with Science 37 to accelerate the clinical development of new therapies worldwide

Technavio analysts forecast the sickle-cell anemia therapeutics market in the US to grow at a CAGR of over 15% during the forecast period, according to their latest market research report.

AIVITA Biomedical, Inc. announced today that it will be featured as a presenting company at the annual Biotech Showcase™ conference taking place January 7-9 at the Hilton San Francisco Union Square in San Francisco, California.

InMed Pharmaceuticals (“InMed” or the “Company”) (TSX : IN) (OTCQX : IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, will be presenting at the Biotech Showcase 2019 on Wednesday, January 9, 2019, at 9:00 AM PT / 12:00 PM ET at the Hilton San Francisco Union Square, in San Francisco, California.

The Pew Charitable Trusts announced today that Novartis has shared data from its antibiotic research programs on Pew’s open-access Shared Platform for Antibiotic Research and Knowledge (SPARK)

Cantel Medical Corporation (NYSE: CMD) announced today that Peter Clifford, Executive Vice President and CFO, will be presenting at the 21st Annual Needham Growth Conference at the Lotte New York Palace Hotel in New York.